A Study to Evaluate the Safety and Immunogenicity of IVX-A12 in Participants of 60 to 85 Years of Age

Trial Identifier: ICVX-12-201
Sponsor: Icosavax, Inc.
Start Date: May 2023
Primary Completion Date: June 2023
Study Completion Date: October 2024
Condition: Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
United States, Arizona Tempe, Arizona, United States, 85281
United States, Florida Hollywood, Florida, United States, 33024
United States, Georgia Stockbridge, Georgia, United States, 30281
United States, Idaho Meridian, Idaho, United States, 83642
United States, Idaho Nampa, Idaho, United States, 83587
United States, Kansas Lenexa, Kansas, United States, 66219
United States, Kentucky Lexington, Kentucky, United States, 40509
United States, Nebraska Omaha, Nebraska, United States, 68134
United States, New York Rochester, New York, United States, 14609
United States, Texas Brownsville, Texas, United States, 78520